Who has invested in OMass Therapeutics?

Syncona, Oxford Sciences Innovation, GV are named among the investors backing OMass Therapeutics.

OMass Therapeutics Funding: $190M Raised, Series A (2022)

OMass Therapeutics funding overview

OMass Therapeutics is based in Oxford, UK. OMass Therapeutics has raised $190M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in January 2022. The round record for OMass Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include Syncona, Oxford Sciences Innovation, GV. 3 distinct backers are named across the disclosed rounds.

OMass Therapeutics at a glance

Total raised: $190M
Latest round: Series A
Latest round date: January 2022
Headquarters: Oxford, UK
Notable investors: Syncona, Oxford Sciences Innovation, GV

Frequently asked about OMass Therapeutics funding

How much has OMass Therapeutics raised?: OMass Therapeutics has raised $190M in total disclosed funding across the rounds on record.
Who has invested in OMass Therapeutics?: Syncona, Oxford Sciences Innovation, GV are named among the investors backing OMass Therapeutics.
What was the latest OMass Therapeutics funding round?: The most recent disclosed round is a Series A, announced in January 2022.
Where is OMass Therapeutics based?: OMass Therapeutics is based in Oxford, UK.
When did OMass Therapeutics last raise?: The last disclosed OMass Therapeutics round closed in January 2022 at Series A.

Round data for OMass Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Oxford and backer lists below.

OMass Therapeutics Funding: $190M Raised, Series A (2022)

OMass Therapeutics funding overview

OMass Therapeutics at a glance

Frequently asked about OMass Therapeutics funding

Companies related to OMass Therapeutics (28)

Browse related funding lists (5)